A unit of the Swiss drug maker would acquire Seragon, a privately held biotechnology firm based in San Diego that was spun off from Aragon Pharmaceuticals last year.
via NYT > Business Day http://ift.tt/1m7SP4t
via WordPress http://ift.tt/1xfu0Yc
No comments:
Post a Comment